Abstract
This Frost & Sullivan research service titled Strategic Analysis of the Kenyan
Diabetes Markets provides an overview of the Kenyan healthcare industry in the
context of diabetes treatment drugs as divided between type I and type II
diabetics. In this research, Frost & Sullivan' s expert analysts thoroughly
examine the key industry challenges, drivers, restraints and trends. Also
provided are revenue forecasts and strategic recommendations.
This analysis is available through our Pharmaceuticals and Biotechnology
Growth Partnership Services programme. With this programme, clients receive
industry-leading market research such as this, along with technical and
econometric data and many interactive features including Analyst Inquiry Time
and Client Councils.
View Cart
